Elevance Health Strategy and Business Model

Executive Overview

Understanding the strategy of Elevance Health starts with seeing it as more than a U.S. health insurer. Elevance Health is one of the largest managed-care organizations in the United States, combining Blue Cross Blue Shield health plans in 14 states with a national services platform, Carelon, that spans pharmacy, care delivery, behavioral health, and other healthcare enablement activities. The company traces its roots to 1944, is headquartered in Indianapolis, Indiana, and reported approximately $171.3 billion of operating revenue in fiscal 2023. Historically known as Anthem and, before that, WellPoint, Elevance Health now positions itself as a broader “whole health” company rather than a pure payer.

That strategic shift matters. Elevance Health still generates most of its revenue from recurring premium and administrative-fee streams tied to commercial, Medicare, and Medicaid members, but it is also trying to diversify earnings through Carelon’s higher-value services and specialty capabilities. Its industry is shaped by regulation, medical-cost inflation, provider contracting, government reimbursement, and annual pricing cycles. Geographically, the company is overwhelmingly U.S.-focused, with strong local-market positions in its licensed Blue territories and a nationwide reach through national accounts, government programs, pharmacy, and care-services businesses.

Elevance Health at a Glance

Logo
Common name	Elevance Health
Full legal name	Elevance Health, Inc.
Headquarters	Indianapolis, Indiana, United States
Ownership	Publicly traded; widely held by institutional investors, with no controlling shareholder publicly disclosed
Ticker	ELV
Exchange	NYSE - New York Stock Exchange
Market Cap	$85.74B
Revenue (FY2024)	$176.81B
Founding / major historical milestones	Origins in 1944 and 1946 through Indiana Blue Cross and Blue Shield predecessors; Anthem formed in 1996; public demutualization in 2001; acquisition of WellPoint Health Networks in 2004; renamed Anthem in 2014; renamed Elevance Health in 2022
Industry or industries	Managed care, health insurance, pharmacy benefit management, healthcare services
Key products or services	Commercial medical insurance, administrative services for self-funded employers, Medicaid managed care, Medicare Advantage, Medicare Part D, pharmacy benefit management, specialty pharmacy, behavioral health, care management, healthcare services
Geographic footprint	United States; Blue-branded health plans in 14 states, with national employer, pharmacy, and care-services operations
Business segments as officially reported	Health Benefits; CarelonRx; Carelon Services; Corporate & Other
Company website	https://www.elevancehealth.com/

1. What Is the Strategy of Elevance Health?

Based on Elevance Health’s fiscal 2023 public filings and 2024 investor communications, the company’s strategy is to evolve from a traditional health insurer into a broader, integrated health platform that combines health benefits, pharmacy, behavioral, and care-delivery capabilities. The clearest way to frame that strategy is through the “Playing to Win” lens.

1. 1a. What is the winning aspiration of Elevance Health?

   Elevance Health publicly frames its mission as improving the health of humanity and its ambition as becoming a trusted lifetime health partner. In practical business terms, “winning” appears to mean three things at once: maintaining scale and relevance in core health benefits, improving affordability and outcomes for members, and building a more diversified earnings base through Carelon. The strategic aspiration is not simply to insure lives, but to shape more of the healthcare value chain around whole-person care, pharmacy, behavioral health, and data-enabled navigation.

2. 1b. Where does Elevance Health play?

   Elevance Health plays primarily in the U.S. healthcare market. Its main arenas are commercial employer-sponsored health coverage, individual coverage including Affordable Care Act marketplaces, Medicaid managed care, Medicare Advantage and related senior products, pharmacy benefit management, specialty pharmacy, behavioral health, and care-services offerings sold internally and to external customers. Geographically, it is strongest in its licensed Blue Cross Blue Shield markets, but it also competes nationally through large employer accounts, government programs, and Carelon services.

3. 1c. How does Elevance Health plan to win?

   Elevance Health’s planned route to advantage is integration rather than pure low-cost scale. The company seeks to combine strong local brands and provider relationships with national capabilities in underwriting, pharmacy, care management, behavioral health, and digital engagement. Its value proposition is that a more connected model can improve member experience, support affordability, and create additional revenue streams beyond insurance premiums. Inference: compared with pure-play insurers, Elevance Health is trying to win by owning more of the service layer around the member, while still preserving the distribution and trust benefits of its Blue plans.

4. 1d. What capabilities must Elevance Health have in place?

   To make that strategy work, Elevance Health needs strong actuarial pricing, provider contracting, claims operations, medical-management and utilization controls, government-program compliance, risk adjustment, quality and Stars performance, specialty pharmacy capabilities, digital product development, and large-scale data and analytics. It also needs acquisition integration capabilities because parts of the Carelon build-out have involved tuck-in deals such as BioPlus, and, as announced in 2024, Paragon Healthcare.

5. 1e. What management systems does Elevance Health require?

   The company’s management system has to balance insurance discipline with healthcare-services execution. That means rigorous oversight of medical cost trend, benefit expense ratio, pricing adequacy, reserve development, and statutory capital, along with quality metrics, member retention, provider-network performance, pharmacy economics, and regulatory compliance across states and federal programs. Because much of the business reprices annually, Elevance Health also needs fast feedback loops between underwriting, medical-management, network contracting, and product design to respond to cost pressure and policy changes.

2. What Are the Current Strategic Initiatives of Elevance Health?

As of the company’s 2023 reporting and 2024 public commentary, Elevance Health’s strategic initiatives are centered on diversification, profitability restoration in pressured government businesses, and deeper integration across benefits and services.

Carelon expansion and diversification

One of Elevance Health’s clearest initiatives is expanding Carelon as a broader healthcare-services platform. That includes scaling pharmacy benefit management through CarelonRx, strengthening specialty pharmacy through the BioPlus acquisition completed in 2023, and broadening site-of-care and infusion capabilities. In March 2024, Elevance Health announced an agreement to acquire Paragon Healthcare; at that time, the transaction was announced rather than completed. Strategically, this initiative is about reducing dependence on traditional underwriting margins and capturing more value in care delivery and specialty services.

Medicaid margin recovery

Elevance Health entered 2024 with clear attention on restoring Medicaid profitability after industry-wide disruption from post-pandemic eligibility redeterminations, acuity changes, and lagging rate updates in some states. Public management commentary emphasized repricing, rate advocacy, membership mix normalization, and execution improvements. This is less about headline growth than about getting an important government line of business back to more acceptable economics.

Medicare Advantage repricing and quality execution

Like other major insurers, Elevance Health has been responding to higher utilization and tighter Medicare Advantage economics. Publicly discussed actions have included bid discipline, benefit redesign, focus on profitability rather than indiscriminate membership growth, and operational work around quality measures and Star ratings. This initiative matters because Medicare Advantage is a large, recurring business, but one where small errors in pricing or quality can materially affect margins.

Whole-health integration

Elevance Health continues to emphasize a “whole health” model that connects medical, pharmacy, behavioral, and social needs. In practice, that means integrating plan benefits with Carelon capabilities, improving care navigation, and using a more coordinated clinical and digital model to manage cost and outcomes. The strategy is meant to differentiate the company from insurers that remain more narrowly focused on risk transfer.

Digital engagement and operating efficiency

The company has also continued to invest in digital member and provider experiences, including consumer-facing navigation tools and workflow simplification. This initiative supports both growth and cost control: better engagement can aid retention and care adherence, while automation and workflow redesign can help offset administrative inflation and scale a more complex enterprise.

3. What Is the Business Model of Elevance Health?

Elevance Health’s business model is built on a mix of recurring insurance premiums, administrative fees, and healthcare-services revenue. In its health-benefits business, customers buy financial protection and network access: employers, individuals, and government sponsors pay for medical coverage, pharmacy benefits, care management, and related services. In self-funded employer plans, the customer often buys administration, network access, and clinical programs rather than full insurance risk.

Most of the model is repeat-driven. Premiums recur monthly; Medicaid and Medicare memberships tend to renew through annual cycles; employer contracts renew annually; and pharmacy and care-management relationships can be sticky if performance is acceptable. One-time revenue is not central. Even acquisition-driven growth is usually aimed at adding recurring service streams.

Pricing power exists, but it is constrained. Commercial premiums can be repriced through annual renewals, but competition, broker influence, and employer budgets limit latitude. Medicaid pricing is highly regulated and depends on state rate-setting. Medicare Advantage economics are shaped by federal benchmarks, risk adjustment, and quality bonuses. In other words, Elevance Health has pricing mechanisms, but not unfettered pricing power.

Business mix matters because different lines have different economics. Fully insured commercial business can be attractive when medical trend is well managed. Self-funded employer administration produces lower revenue but can be capital-light. Medicare and Medicaid offer scale but come with intense regulatory and pricing risk. Carelon’s services and specialty businesses are strategically important because they can diversify earnings and deepen control over the care journey.

Gross margin is not the primary lens in this industry; operating performance is driven more by the spread between premium and medical costs, plus administrative efficiency. Key drivers include benefit expense ratio, risk adjustment accuracy, provider contracting, pharmacy economics, quality performance, and selling, general, and administrative expense discipline. Cash generation is helped by the recurring nature of premiums and the timing difference between premium collection and claim payment, though capital is heavily regulated at the insurance-subsidiary level.

4. What Products and Services Does Elevance Health Sell?

Elevance Health sells both traditional health-benefit products and a growing set of healthcare services.

• Commercial health benefits: Fully insured and self-funded employer medical plans, often paired with network administration, wellness, care-management, and specialty benefits.
• Individual and exchange products: Health plans for individuals buying coverage directly, including Affordable Care Act marketplace offerings.
• Medicaid managed care: Plans serving state Medicaid beneficiaries, including in some markets specialized offerings for higher-need populations.
• Medicare products: Medicare Advantage, Medicare Part D prescription-drug coverage, and other senior-focused offerings.
• Pharmacy benefit management: CarelonRx manages pharmacy benefits, formularies, specialty drug programs, and related pharmacy services.
• Specialty pharmacy: BioPlus expanded Elevance Health’s capabilities in specialty pharmacy, which is strategically important because specialty drugs are a fast-growing share of healthcare spending.
• Care-services offerings: Through Carelon, the company offers behavioral health, care management, clinical and provider-enablement services, and other healthcare support capabilities for internal plans and, in some cases, external customers.

The company’s core revenue still comes from health benefits, but newer growth emphasis has increasingly centered on Carelon and specialty capabilities, where Elevance Health believes it can build a broader, less underwriting-dependent healthcare platform.

5. What Are the Key Competitors or Peers of Elevance Health?

Elevance Health competes across several adjacent markets, so its competitive set varies by product, geography, and customer segment.

Beyond these, Elevance Health also faces competition from regional nonprofit plans, provider-sponsored plans, and specialized services companies in pharmacy, behavioral health, and care enablement.

6. What Is the Marketing Strategy of Elevance Health?

Elevance Health’s marketing strategy is pragmatic and segment-specific rather than centered on broad consumer advertising alone. In commercial health benefits, marketing is closely tied to broker relationships, employer RFPs, local reputation, network breadth, and account retention. The Blue Cross Blue Shield brands used in its licensed markets are important trust signals, especially for employers and members who value broad provider access and local brand familiarity.

In Medicare and individual exchange products, marketing is more consumer-facing. Those businesses typically rely on enrollment-season campaigns, broker support, digital acquisition, local field marketing, and message clarity around benefits, networks, and cost. In Medicaid, “marketing” is often less about mass media and more about winning state procurements, demonstrating compliance and quality performance, and building credibility with community stakeholders.

For Carelon, the approach is closer to business-to-business account-based marketing. The goal is to show payers, providers, and employer-related buyers that Elevance Health can solve specific problems in pharmacy, behavioral health, and care delivery. Overall, marketing appears to be a supporting capability rather than the single defining differentiator; local market position, network strength, government-program execution, and service integration matter more.

7. What Are the Key Customer Segments of Elevance Health?

Elevance Health serves several distinct customer groups:

• Large employers: National and regional employers buying fully insured or self-funded health-benefit solutions.
• Small and mid-sized employers: A more localized segment where brand trust, broker channels, and provider networks matter.
• Individual consumers: Members buying coverage directly, including through Affordable Care Act marketplaces.
• Medicare beneficiaries: Seniors and other eligible members enrolling in Medicare Advantage and related products.
• State Medicaid agencies: Technically the contracting customer in Medicaid managed care, with beneficiaries as end users.
• Providers and other healthcare organizations: Through Carelon and related services, Elevance Health can also serve providers, other payers, and healthcare organizations.

The company is diversified across end markets, but government-related business is strategically important and sensitive to policy and reimbursement. Commercial accounts remain important for cash generation and brand presence, while Carelon expands the customer base beyond traditional insured membership.

8. What Is the Sales Model of Elevance Health?

Elevance Health uses a multi-channel sales model tailored to each line of business.

• Commercial group business: Sold through direct sales teams, account executives, benefit consultants, and broker networks. Large accounts are relationship-driven and often procured through formal RFPs.
• Self-funded employer administration: Sold through consultative enterprise sales, where the value proposition includes network access, administration, analytics, and clinical programs.
• Individual and Medicare products: Sold through a mix of direct-to-consumer channels, licensed agents, brokers, digital enrollment, and call-center support, especially during annual enrollment periods.
• Medicaid managed care: Won primarily through state procurement processes and ongoing contract management, not traditional retail selling.
• Carelon services: Sold through direct business-development teams and existing enterprise relationships, often with a more solution-oriented sales process.

This channel structure affects growth and economics. Broker and consultant influence can compress pricing in commercial markets, while Medicaid growth depends heavily on state wins and contract renewals. The services businesses offer different consultant opportunities because they often require sharper go-to-market design, product packaging, integration, and customer success capabilities than a traditional payer does.

9. In What Geographies Does Elevance Health Operate?

Elevance Health operates primarily in the United States. Its health-benefits footprint is most concentrated in the 14 states where it holds Blue Cross Blue Shield licenses, including major markets such as California, New York, Georgia, Indiana, Ohio, Virginia, and others. Those local-market positions are strategically important because insurance remains regulated at the state level and provider-network economics are highly local.

At the same time, the company is not only a regional insurer. Through national employer accounts, government programs, pharmacy services, and Carelon businesses, Elevance Health has a nationwide operating reach. It maintains corporate, plan, and service operations across multiple states, with Indianapolis serving as the headquarters. Inference: the company is best understood as a U.S.-national enterprise built on a federation of strong local-market positions rather than as a globally diversified healthcare company.

10. Who Are the Owners of Elevance Health?

Elevance Health is a publicly traded company. As reflected in public ownership filings in 2024, its shareholder base is primarily institutional, with large asset managers such as The Vanguard Group, BlackRock, and State Street among the significant holders. No controlling shareholder is publicly disclosed.

11. How Is Elevance Health Organized?

At a practical level, Elevance Health is organized as a holding company over regulated insurance subsidiaries and healthcare-services businesses. For external reporting, it has disclosed four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.

The Health Benefits segment houses the traditional insurance activities across commercial, Medicare, Medicaid, and related products. CarelonRx focuses on pharmacy benefit management and related pharmacy services. Carelon Services includes broader care-delivery and healthcare enablement capabilities. Corporate functions provide enterprise-wide support in finance, legal, technology, compliance, and strategy.

Operationally, the organization also reflects its Blue plan structure. Local health plans matter because provider contracting, regulatory relationships, and brand presence are state-specific. That means Elevance Health has to balance centralized scale benefits with local-market responsiveness.

12. How Does Elevance Health Operate?

Day to day, Elevance Health operates through a combination of insurance, care-management, pharmacy, and service workflows.

• Product and pricing cycle: The company designs benefit products, prices risk, submits bids where required, and renews employer and government contracts on recurring cycles.
• Network management: It contracts with hospitals, physicians, pharmacies, and other providers, balancing adequacy, unit cost, quality, and member access.
• Claims and payment: It adjudicates medical and pharmacy claims at large scale, manages payment integrity, and monitors utilization patterns.
• Clinical and care management: It runs programs intended to improve adherence, manage high-cost members, coordinate behavioral and medical care, and reduce avoidable utilization.
• Government-program execution: Medicaid and Medicare operations require bid discipline, compliance, member service, quality measurement, and frequent interaction with regulators.
• Carelon operations: These activities extend beyond underwriting into pharmacy services, specialty capabilities, and other healthcare enablement functions.

The biggest operational performance drivers are medical-cost trend, rate adequacy, provider contracting outcomes, claim and utilization management, pharmacy trend, quality performance, and administrative efficiency. Because the company sits at the intersection of patients, providers, employers, and government payers, execution complexity is high even when the products themselves look financially standardized.

13. What Are the Growth Opportunities for Elevance Health?

The most plausible growth opportunities for Elevance Health, based on public strategy and reasonable synthesis, include the following:

• Scaling Carelon: Expanding pharmacy, specialty pharmacy, infusion, behavioral health, and other services can diversify earnings beyond premium underwriting.
• Selling more services to external customers: Elevance Health can potentially use internal capabilities developed for its own plans as products for other payers, providers, and healthcare organizations.
• Medicare and senior-focused growth: Despite recent margin pressure, aging demographics keep Medicare-related markets structurally attractive if pricing and quality execution improve.
• Medicaid normalization and selective expansion: Once post-redetermination disruption eases and rates become more aligned with acuity, Medicaid can again contribute more predictably.
• Specialty pharmacy and site-of-care economics: This is a large and growing cost category in U.S. healthcare, making it strategically important for both cost control and revenue capture.
• Digital engagement and productivity: Better digital experiences can improve retention, lower service costs, and support more coordinated clinical interventions.
• Tuck-in acquisitions: Elevance Health has shown interest in acquiring capabilities that support Carelon’s expansion.

Main constraints include medical-cost inflation, rate lags in government programs, regulatory changes, Star ratings pressure, integration risk, and the challenge of competing against other vertically integrated healthcare companies with large services platforms.

14. What Is the History of Elevance Health?

Elevance Health traces its roots to Indiana Blue Cross and Blue Shield predecessors founded in 1944 and 1946. The modern corporate lineage includes several major identity shifts and acquisitions.

• 1996: Anthem, Inc. was formed through the reorganization of Blue Cross and Blue Shield of Indiana.
• 2001: The company completed its public demutualization and became publicly traded.
• 2004: Anthem acquired WellPoint Health Networks, and the combined company adopted the WellPoint name, creating one of the largest U.S. health insurers.
• 2012: WellPoint acquired Amerigroup, significantly expanding its Medicaid managed-care presence.
• 2014: The company changed its name from WellPoint to Anthem to align the corporate identity with the better-known operating brand.
• 2017: Anthem’s proposed acquisition of Cigna was blocked and did not close.
• 2022: Anthem changed its corporate name to Elevance Health to reflect a broader healthcare-services strategy beyond traditional insurance.
• 2023 onward: The company continued building Carelon, including the BioPlus acquisition in 2023 and the announced Paragon Healthcare transaction in 2024.

15. What Are the Key Brands Owned by Elevance Health?

Brands matter at Elevance Health, but not in a simple single-brand way. The company operates with a portfolio of brands that serve different audiences.

Anthem and Blue Cross Blue Shield plan brands

In many of its core insurance markets, the most important customer-facing names are Anthem and local Blue Cross Blue Shield brands. These carry substantial trust and network recognition. It is important to note that the Blue names and marks are used under license from the Blue Cross Blue Shield Association rather than being a globally owned corporate brand in the usual sense.

Empire

Empire is a key regional brand in New York and remains important because local-market brand equity still matters in insurance, especially where provider relationships and broker familiarity are strong.

Wellpoint

Wellpoint has been used in certain government-focused and consumer-facing contexts. The brand is relevant where Elevance Health wants a differentiated identity separate from its traditional commercial Blue brands.

Carelon

Carelon is the strategic growth brand for healthcare services. It signals Elevance Health’s push beyond insurance into pharmacy, behavioral, and broader care-enablement offerings. For investors and partners, Carelon is one of the clearest indicators of the company’s portfolio shift.

Elevance Health

Elevance Health itself is mainly the corporate brand used with investors, partners, and broader stakeholders. In many end markets, the local operating brands are more commercially important than the parent name.

16. What Is the Technology Strategy of Elevance Health?

Technology is central to Elevance Health’s competitiveness, but mostly as an internal enabler and engagement layer rather than as a standalone software business. The company’s technology strategy appears to revolve around linking consumer engagement, clinical data, pharmacy, claims, and care management so that it can operate a more integrated whole-health model.

A visible part of that strategy is digital member engagement, including the Sydney Health platform, which serves as a consumer-facing front door for navigation, benefits access, and care-related interactions. On the enterprise side, technology supports pricing, risk adjustment, provider-network analytics, claims automation, utilization management, and quality measurement. Within Carelon, technology and analytics also support healthcare-services workflows and cross-enterprise coordination.

In practical terms, Elevance Health’s technology priorities appear to be: improving the member and provider experience, lowering administrative friction, sharpening medical-management decisions, and connecting services that used to sit in separate silos. That matters because in managed care, small improvements in workflow accuracy, coding, and engagement can have outsized financial effects.

17. What Is the Finance Strategy of Elevance Health?

Elevance Health’s finance strategy is shaped by the realities of being both a regulated insurer and a capital allocator building adjacent services businesses. The company needs to preserve strong statutory capital and liquidity at insurance subsidiaries, manage medical-cost volatility, and still fund growth initiatives such as Carelon expansion and selective acquisitions.

Capital allocation appears to follow a fairly standard large-cap managed-care pattern: reinvest in core operations, fund targeted M&A that adds capabilities, maintain balance-sheet flexibility, and return excess capital to shareholders through dividends and share repurchases. Financial discipline is especially important because underwriting errors, rate lag, or adverse utilization trends can pressure earnings quickly in Medicare and Medicaid.

From an operating-finance standpoint, the key levers are pricing adequacy, benefit expense ratio, administrative cost control, reserve discipline, and cash upstreaming from regulated subsidiaries to the parent. Inference: the finance function is not just a reporting engine at Elevance Health; it is a strategic control tower for margin management and capital deployment.

18. What Major Acquisitions Has Elevance Health Made?

Acquisitions have played an important role in Elevance Health’s history and in its more recent portfolio shift.

• WellPoint Health Networks (2004): Anthem’s acquisition of WellPoint was transformational. It created a much larger national managed-care company and led to the adoption of the WellPoint name for the combined enterprise.
• Amerigroup (2012): This acquisition materially expanded the company’s Medicaid managed-care footprint and capabilities, strengthening its position in government programs.
• Simply Healthcare Holdings (2015): Helped deepen Medicaid and Medicare capabilities in Florida, an important government-program market.
• BioPlus (closed 2023): Expanded Elevance Health’s specialty pharmacy capabilities and supported the strategic build-out of Carelon.
• Paragon Healthcare (announced 2024): Announced in March 2024, this deal was positioned as a way to add infusion and related specialty-services capabilities. As announced at that time, it should be understood as a pending transaction rather than a completed one unless later confirmed as closed.

The pattern is consistent: large historical deals built scale in insurance, while more recent deals are increasingly about capability expansion in services, specialty care, and the broader healthcare platform.

19. How Companies Like Elevance Health Leverage Independent Consultants through Umbrex

Umbrex has built a global community of more than 8,000 independent management consultants based in over 50 countries, including many alumni of McKinsey, Bain, BCG, and other top firms. Companies like Elevance Health use Umbrex when they need targeted expertise with that level of training, but do not need a full traditional consulting team and its overhead. For a company operating across health benefits, government programs, pharmacy, care services, technology, and integration, independent consultants can be especially useful on focused, high-stakes workstreams.

• Medicaid margin-recovery diagnostics covering rate adequacy, acuity shifts, utilization, claims leakage, and operational remediation priorities.
• Medicare Advantage profitability improvement, including bid support, product redesign, broker-channel economics, and Stars-related execution planning.
• Post-merger integration support for Carelon acquisitions such as specialty pharmacy or infusion assets, including synergy tracking and operating-model design.
• Carelon growth strategy projects that clarify where Elevance Health should build, buy, or partner across pharmacy, behavioral health, and care-enablement services.
• Provider-network optimization and value-based care design, including local market economics, contracting strategy, and performance dashboards.
• Administrative-cost and SG&A productivity programs in claims, contact center, prior authorization, and shared services.
• Digital member journey redesign across enrollment, service, navigation, and retention touchpoints, aligned with the company’s whole-health strategy.
• State Medicaid procurement support, including win themes, proposal design, competitive positioning, and PMO support for mobilization after award.
• Enterprise AI and analytics roadmaps for use cases such as payment integrity, care-gap identification, contact-center assistance, and workflow automation.
• Capital allocation and portfolio strategy work evaluating where incremental investment should go across health benefits, Carelon, specialty capabilities, and tuck-in M&A.